Minimally-Myelosuppressive Asparaginase-Containing Induction Regimen for Treatment of a Jehovah’s Witness with mutant IDH1/NPM1/NRAS Acute Myeloid Leukemia

Treatment of patients with acute myeloid leukemia (AML) who do not wish to accept blood product transfusion, including Jehovah’s Witnesses, is extremely challenging. The use of conventional chemotherapy for induction of complete remission (CR) results in profound anemia and thrombocytopenia requirin...

Descripción completa

Detalles Bibliográficos
Autores principales: Emadi, Ashkan, Bade, Najeebah A., Stevenson, Brandi, Singh, Zeba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Short Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812376/
https://www.ncbi.nlm.nih.gov/pubmed/27064021
http://dx.doi.org/10.3390/ph9010012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812376/
https://www.ncbi.nlm.nih.gov/pubmed/27064021
http://dx.doi.org/10.3390/ph9010012

Ejemplares similares